Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management. [PDF]
Abdullaev SP +7 more
europepmc +1 more source
TIAM1 drives prostatic branching phenotype and is a potential therapeutic target for benign prostatic hyperplasia. [PDF]
Khedmatgozar H +15 more
europepmc +1 more source
Report of a prostate abscess mistakenly diagnosed as benign prostatic hyperplasia. [PDF]
Wu Z, Zhang M, Wu Y.
europepmc +1 more source
Use of Epilobium parviflorum in the Treatment of Benign Prostatic Hyperplasia in Canines. [PDF]
Cazzuli G +5 more
europepmc +1 more source
A comparative study of transurethral 450 nm DiLVP and 1470 nm DiLEP in the treatment of benign prostatic hyperplasia. [PDF]
Wang Z, Xing Q, Gao X, Qiu M, Zhang L.
europepmc +1 more source
Doppler Ultrasonography in the Diagnosis of Dogs With Benign Prostatic Hyperplasia and Investigation of the Efficacy of Finasteride in Treatment. [PDF]
Esin B, Kaya C, Esin Ç.
europepmc +1 more source
Prospective observational study of oxidative stress in the pathology of benign prostatic hyperplasia with bladder diverticulum. [PDF]
Yin S, Qiu Y.
europepmc +1 more source

